Related Experiment Video
Updated: Apr 2, 2026

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
Published on: February 10, 2022
Cardiac Surgery 2025 Reviewed
Hristo Kirov1, Tulio Caldonazo1, Murat Mukharyamov1
1Department of Cardiothoracic Surgery, Friedrich-Schiller-University of Jena, University Hospital Jena, Jena, Germany.
Coronary artery bypass grafting (CABG) offers superior long-term outcomes for complex coronary artery disease compared to percutaneous coronary intervention. Transcatheter therapies show promise for mitral/tricuspid disease, but surgery remains optimal for consistent long-term results.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Clinical Evidence Synthesis
Background:
- Systematic review of cardio-surgical literature for 2025.
- Focus on randomized and observational evidence in cardiovascular therapies.
- Analysis of recent guidelines and their impact on treatment decisions.
Purpose of the Study:
- To provide a results-oriented summary of key cardio-surgical publications from the past year.
- To evaluate the comparative effectiveness of different treatment modalities for coronary artery disease and valvular heart disease.
- To inform patient-specific decision-making based on current evidence.
Main Methods:
- Systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Analysis of randomized trials, meta-analyses, and registry data.
- Synthesis of evidence regarding coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and transcatheter/surgical valve therapies.
Main Results:
- Coronary artery bypass grafting (CABG) demonstrates superior long-term outcomes over percutaneous coronary intervention for complex coronary artery disease, primarily due to reduced myocardial infarctions.
- Atrial fibrillation post-CABG is common but has negligible long-term impact; prolonged dual antiplatelet therapy offers no benefit and increases bleeding risk.
- Transcatheter mitral/tricuspid valve therapies improve symptoms and quality of life, but surgery provides more consistent long-term outcomes, especially in experienced centers. Controversies exist regarding aortic stenosis treatment guidelines.
Conclusions:
- Coronary artery bypass grafting remains the preferred strategy for complex coronary artery disease.
- While transcatheter therapies are advancing for other valve diseases, surgical intervention offers more robust long-term results.
- Evidence synthesis highlights the ongoing debate and evolving landscape in cardiovascular treatment strategies, emphasizing the need for individualized patient care.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview
Aneurysm IV: Nursing Management
Cardiac Catheterization IV: Nursing Management

